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Background: The association of peroxisome proliferator-activated receptor delta (PPARD) +294T > C polymorphism
and serum lipid levels is inconsistent in several previous studies. Bai Ku Yao is an isolated subgroup of the Yao
minority in China. The present study was undertaken to detect the association of PPARD +294T > C (rs2016520)
polymorphism and several environmental factors with serum lipid levels in the Guangxi Bai Ku Yao and Han
populations.
Methods: A total of 609 subjects of Bai Ku Yao and 573 participants of Han Chinese were randomly selected from
our previous stratified randomized cluster samples. Genotyping of the PPARD +294T > C polymorphism was
performed by polymerase chain reaction and restriction fragment length polymorphism combined with gel
electrophoresis, and then confirmed by direct sequencing.
Results: The levels of serum total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), apolipoprotein
(Apo) AI and ApoB were lower in Bai Ku Yao than in Han (P < 0.001 for all). The frequency of T and C alleles was
77.50% and 22.50% in Bai Ku Yao, and 72.43% and 27.57% in Han (P < 0.01); respectively. The frequency of TT, TC
and CC genotypes was 60.59%, 33.83% and 5.53% in Bai Ku Yao, and 52.18%, 40.50% and 7.32% in Han (P < 0.05);
respectively. The subjects with CC genotype in Bai Ku Yao had higher serum LDL-C and ApoB levels and lower the
ratio of ApoAI to ApoB than the subjects with TT and TC genotypes in females but not in males. The C allele
carriers in Han had higher serum TC levels in males (P < 0.01) and ApoB levels in females (P < 0.05) than the C
allele noncarriers. Serum TC and ApoB levels were correlated with genotypes in Han (P < 0.05 for each) but not in
Bai Ku Yao. Serum lipid parameters were also correlated with sex, age, body mass index, alcohol consumption,
cigarette smoking, and blood pressure in both ethnic groups.
Conclusions: These results suggest that the association of PPARD +294T > C polymorphism and serum lipid levels
is different between the Bai Ku Yao and Han populations. The discrepancy between the two ethnic groups might
partly result from different PPARD +294T > C polymorphism or PPARD gene-enviromental interactions.
Introduction
Elevated levels of total cholesterol (TC), triglyceride
(TG), low-density lipoprotein cholesterol (LDL-C) and
apolipoprotein (Apo) B, together with decreased levels
of high-density lipoprotein cholesterol (HDL-C), and
ApoAI, are associated with an increased risk of coronary
artery disease (CAD) [1-4]. Genetic and environmental
factors [4-10] and their interactions [11,12] are believed
to regulate both metabolic and cellular function, and the
serum lipid concentrations. Twin and family studies
have shown the variable estimates of heritability for
plasma lipid phenotypes ranging from 40 to 60% in dif-
ferent studies supporting the idea of a strong genetic
component in the development of dyslipidemia [13-17].
Peroxisome proliferator-activated receptors (PPARs)
are nuclear transcription factors involved in the
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includes PPAR-alpha (PPARA), PPAR-gamma (PPARG),
and PPAR-delta (PPARD). PPARA is mainly expressed
in liver, muscle, kidney and heart, PPARG is most abun-
dant in adipocytes, intestinal cells and macrophages and
PPARD is expressed in many tissues [18-20]. Each sub-
group is activated by a certain variety of fatty acids and
their derivatives and by specific pharmacological ligands.
After forming obligate heterodimers with the retinoid ×
receptor, PPARs bind to specific elements in the promo-
ter region of target genes, thereby altering metabolism
by activating a network of downstream genes [21,22].
PPARs are encoded by separate genes and characterized
by distinct tissue and developmental distribution pat-
terns. The PPARD gene, located on chromosome
6p21.2-p21.1, is involved in cellular transport, storage
and metabolism of lipids [23], which ultimately trans-
lates into a metabolic response. This gene is equally
actively expressed in both adipose tissue and skeletal
muscles, primarily in slow twitch muscle fibers. Treat-
ment of obese rhesus monkeys with the synthetic
PPARD agonist GW501516 resulted in an increase of
HDL-C levels and a decrease of plasma TG [24,25].
In addition, db/db mice expressing an activated form of
PPARD are resistant to obesity and hyperlipidemia
when overfed and muscle-specific overexpression of the
receptor increased the number of muscle fibers with
high oxidative metabolic capability [26,27]. These results
suggest that PPARD may play a role in the development
of metabolic perturbations associated with dyslipidemia
and predisposing to atherosclerosis. The +294T > C
(rs2016520) polymorphism in the 5’-untranslated region
in exon 4 of the PPARD gene is located 87 nucleotides
upstream of the start codon. It was shown that the sin-
gle nucleotide polymorphism (SNP) influenced binding
of Sp-1 resulting in higher transcriptional activity for
the rare C allele than the common T allele [28]. Several
previous studies have showed that the PPARD +294T >
C polymorphism was associated with modifications of
serum lipid concentrations in healthy subjects and the
risk of CAD [28-35] in dyslipidemic women and
hypercholesterolemic men and cholesterol metabolites
in Alzheimer’s disease patients [36]. But the results are
inconsistent in diverse populations [34,37].
There are 56 ethnic groups in China. Han is the lar-
gest ethnic group and Yao is the eleventh largest minor-
ity among the 55 minority groups according to the
population size. Bai Ku Yao (White-trouser Yao), an iso-
lated branch of the Yao minority, is named so because
all of men wear white knee-length knickerbockers. The
population size is about 30000. Because of isolation
from the other ethnic groups, the special customs and
cultures including their clothing, intra-ethnic marriages,
ballad, funeral, bronze drum, spinning top, dietary
habits, and corn wine and rum intakes are still comple-
tely preserved to the present day. In previous epidemio-
logical studies, we showed that several serum lipid
parameters were lower in Bai Ku Yao than in Han Chi-
nese from the same area [6,7]. These differences in
serum lipid profiles are still not well known. We
hypothesized that the genetic and environmental risk
factors for dyslipidemia may be different between the
two ethnic groups. Therefore, the aim of the present
study was to detect the association of PPARD +294T >
C polymorphism and several environmental factors with




A total of 609 participants of Bai Ku Yao who reside in
Lihu and Baxu villages in Nandan County, Guangxi
Zhuang Autonomous Region, People’s Republic of China
were randomly selected from our previous stratified ran-
domized cluster samples [6,7]. The ages of the subjects
ranged from 15 to 80 years, with an average age of 41.75
± 15.46 years. There were 288 males (47.29%) and 321
females (52.71%). All subjects were rural agricultural
workers. The subjects accounted for 2.03% of total Bai
Ku Yao population. During the same period, a total of
573 subjects of Han Chinese who reside in the same vil-
lages were also randomly selected from our previous stra-
tified randomized cluster samples [6,7]. The average age
of the subjects was 42.18 ± 15.63 years (range 15 to 80).
There were 260 men (45.38%) and 313 women (54.62%).
All of them were also rural agricultural workers. All
study subjects were essentially healthy and had no evi-
dence of any chronic illness, including hepatic, renal, or
thyroid. The participants with a history of heart attack or
myocardial infarction, stroke, congestive heart failure,
diabetes or fasting blood glucose ≥ 7.0 mmol/L deter-
mined by glucose meter have been excluded. The partici-
pants were not taking medications known to affect serum
lipid levels (lipid-lowering drugs such as statins or
fibrates, beta-blockers, diuretics, or hormones). The pre-
sent study was approved by the Ethics Committee of the
First Affiliated Hospital, Guangxi Medical University.
Informed consent was obtained from all subjects after
they received a full explanation of the study.
Epidemiological survey
The survey was carried out using internationally stan-
dardized methods, following a common protocol [38].
I n f o r m a t i o no nd e m o g r a p h i c s, socioeconomic status,
and lifestyle factors was collected with standardized
questionnaires. The alcohol information included ques-
t i o n sa b o u tt h en u m b e ro fl i a n g s( a b o u t5 0g )o fr i c e
wine, corn wine, rum, beer, or liquor consumed during
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categorized into groups of grams of alcohol per day: <
25 and ≥ 25. Smoking status was categorized into
groups of cigarettes per day: < 20 and ≥ 20. At the phy-
sical examination, several anthropometric parameters,
such as height, weight, and waist circumference were
measured. Sitting blood pressure was measured three
times with the use of a mercury sphygmomanometer
after the subjects had a 5-minute rest, and the average
of the three measurements was used for the level of
blood pressure. Systolic blood pressure was determined
by the first Korotkoff sound, and diastolic blood pres-
sure by the fifth Korotkoff sound. Body weight, to the
nearest 50 grams, was measured using a portable bal-
ance scale. Subjects were weighed without shoes and in
a minimum of clothing. Height was measured, to the
nearest 0.5 cm, using a portable steel measuring device.




A venous blood sample of 8 mL was obtained from all
subjects between 8 and 11 AM, after at least 12 hours of
fasting, from a forearm vein after venous occlusion for few
seconds in a sitting position. A part of the sample (3 mL)
was collected into glass tubes and allowed to clot at room
temperature, and used to determine serum lipid levels.
Another part of the sample (5 mL) was transferred to
tubes with anticoagulate solution (4.80 g/L citric acid,
14.70 g/L glucose, and 13.20 g/L tri-sodium citrate) and
used to extract DNA. Immediately following clotting
serum was separated by centrifugation for 15 minutes at
3000 rpm. The levels of TC, TG, HDL-C, and LDL-C
in samples were determined by enzymatic methods with
commercially available kits, Tcho-1, TG-LH (RANDOX
Laboratories Ltd., Ardmore, Diamond Road, Crumlin
Co. Antrim, United Kingdom, BT29 4QY), Cholestest N
HDL, and Cholestest LDL (Daiichi Pure Chemicals Co.,
Ltd., Tokyo, Japan); respectively. Serum ApoAI and ApoB
levels were detected by the immunoturbidimetric immu-
noassay using a commercial kit (RANDOX Laboratories
Ltd.). All determinations were performed with an autoana-
lyzer (Type 7170A; Hitachi Ltd., Tokyo, Japan) in the Clin-
ical Science Experiment Center of the First Affiliated
Hospital, Guangxi Medical University [6,7].
DNA amplification and genotyping
Genomic DNA was isolated from peripheral blood leuko-
cytes using the phenol-chloroform method [8-12]. The
extracted DNA was stored at 4°C until analysis. Genotyp-
ing of the PPARD +294T > C polymorphism was per-
formed by polymerase chain reaction and restriction
fragment length polymorphism (PCR-RFLP) [35,37]. PCR
amplification was performed using 5’-CATGGTATAG
CACTGCAGGAA-3’ and 5’-CTTCC
TCCTGTGGCTGCTC-3’ (Sangon, Shanghai, People’s
Republic of China) as the forward and reverse primer
pairs; respectively. Each amplification reaction was per-
formed using 100 ng genomic DNA in 25 μLo fr e a c t i o n
mixture consisting of 1.0 μLo fe a c hp r i m e r( 1 0μmol/L),
12.5 μL 2 × Taq PCR MasterMix (constituent: 0.1 U Taq
polymerase/μL, 500 μM dNTP each and PCR buffer).
After initial denaturizing at 95°C for 5 min, the reaction
mixture was subjected to 30 cycles of 45 s denaturation
at 94°C, 45 s annealing at 62°C and extension 45 s at 72°
C, followed by a final 8 min extension at 72°C. After elec-
trophoresis on a 2.0% agarose gel with 0.5 μg/mL ethi-
dium bromide, the amplification products were
visualized under ultraviolet light. Then 5 U of BslI
restriction enzyme was added directly to the PCR pro-
ducts (6 μL) and digested at 55°C overnight. After restric-
tion enzyme digestion of the amplified DNA, the
genotypes were identified by electrophoresis on 2.5%
agarose gels and visualized with ethidium-bromide stain-
ing ultraviolet illumination. The genotypes were scored
by an experienced reader blinded to epidemiological data
and serum lipid levels. Six samples (TT, TC and CC gen-
otypes in two; respectively) detected by the PCR-RFLP
were also confirmed by direct sequencing. The PCR pro-
ducts were purified by low melting point gel electrophor-
esis and phenol extraction, and then the DNA sequences
were analyzed in Shanghai Sangon Biological Engineering
Technology & Services Co., Ltd., People’sR e p u b l i co f
China.
Diagnostic criteria
The normal values of serum TC, TG, HDL-C, LDL-C,
ApoAI, ApoB levels, and the ratio of ApoAI to ApoB in
our Clinical Science Experiment Center were 3.10-5.17,
0.56-1.70, 0.91-1.81, 2.70-3.20 mmol/L, 1.00-1.78, 0.63-
1.14 g/L, and 1.00-2.50; respectively. The individuals
with TC > 5.17 mmol/L and/or TG > 1.70 mmol/L were
defined as hyperlipidemic [6,7]. Hypertension was diag-
nosed according to the criteria of 1999 World Health
Organization-International Society of Hypertension
Guidelines for the management of hypertension [39,40].
The diagnostic criteria of overweight and obesity were
according to the Cooperative Meta-analysis Group of
China Obesity Task Force. Normal weight, overweight




Epidemiological data were recorded on a pre-designed
form and managed with Excel software. All statistical
analyses were done with the statistical software package
SPSS 13.0 (SPSS Inc., Chicago, Illinois). Quantitative
variables were expressed as mean ± standard deviation
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quartile ranges). Qualitative variables were expressed as
percentages. Allele frequency was determined via direct
counting, and the standard goodness-of-fit test was used
to test the Hardy-Weinberg equilibrium. Difference in
genotype distribution between the groups was obtained
using the chi-square test. The difference in general char-
acteristics between Bai Ku Yao and Han was tested by
the Student’su n p a i r e dt-test. The association of geno-
types and serum lipid parameters was tested by analysis
of covariance (ANCOVA). Se x ,a g e ,B M I ,b l o o dp r e s -
sure, alcohol consumption, cigarette smoking were
adjusted for the statistical analysis. In order to evaluate the
association of serum lipid levels with genotypes (TT = 1,
TC = 2, CC = 3) and several environment factors, multiple
linear regression analysis with stepwise modeling was also
performed in the combined population of Bai Ku Yao and
Han, Bai Ku Yao, Han; respectively. A P value of less than
0.05 was considered statistically significant.
Results
General characteristics and serum lipid levels
Table 1 gives the general characteristics and serum
lipid levels between the Bai Ku Yao and Han
populations. The levels of height, weight, BMI, serum
T C ,H D L - C ,A p o A Ia n dA p o Bw e r el o w e ri nB a iK u
Y a ot h a ni nH a nC h i n e s e( P < 0.05-0.001), whereas the
ratio of ApoAI to ApoB was higher in Bai Ku Yao than
in Han (P < 0.05). There were no significant differ-
ences in the levels of systolic blood pressure, diastolic
blood pressure, pulse pressure, serum TG, LDL-C, age
structure, the percentages of subjects who consumed
alcohol or smoked cigarettes, or the ratio of male to
female between the two ethnic groups (P >0 . 0 5f o r
all).
Results of electrophoresis and genotyping
After the genomic DNA of the samples was amplified by
PCR and imaged by 2.0% agarose gel electrophoresis, the
purpose gene of 269 bp nucleotide sequences could be
found in all samples (Figure 1). The genotypes identified
were named according to the presence or absence of the
enzyme restriction sites, when a T to C transversion at
+294 locus of the PPARD gene. The presence of the
cutting site indicates the C allele, while its absence indi-
cates the T allele (cannot be cut). Thus, the TT geno-
type is homozygote for the absence of the site (band at
269 bp), TC genotype is heterozygote for the absence
Table 1 Comparison of demographic, lifestyle characteristics and serum lipid levels between Bai Ku Yao and Han
Chinese
Parameter Bai Ku Yao Han Chinese t (c)
2 P
Number 609 573 - -
Male/female 288/321 260/313 0.436 0.509
Age (years) 41.75 ± 15.46 42.18 ± 15.63 -0.480 0.631
Height (cm) 152.56 ± 7.40 154.33 ± 8.40 -3.828 0.000
Weight (kg) 51.65 ± 7.39 53.62 ± 8.92 -4.151 0.000
Body mass index (kg/m
2) 22.14 ± 2.41 22.48 ± 3.03 -2.109 0.035
Systolic blood pressure (mmHg) 119.71 ± 17.96 120.73 ± 16.00 -1.036 0.300
Diastolic blood pressure (mmHg) 75.80 ± 9.64 75.97 ± 10.40 -0.293 0.769
Pulse pressure (mmHg) 43.91 ± 13.24 44.76 ± 11.00 -1.217 0.224
Cigarette smoking [n (%)]
Nonsmoker 423 (69.5) 404 (70.5)
< 20 cigarettes/day 82 (13.4) 72 (12.6)
≥ 20 cigarettes/day 104 (17.1) 97 (16.9) 0.233 0.890
Alcohol consumption [n (%)]
Nondrinker 343 (56.3) 342 (59.7)
< 25 g/day 163 (26.8) 149 (26.0)
≥ 25 g/day 103 (16.9) 82 (14.3) 1.919 0.383
Total cholesterol (mmol/L) 4.35 ± 0.92 4.76 ± 1.03 -7.215 0.000
Triglycerides (mmol/L) 0.98 (0.78) 1.01 (0.66) -0.956 0.339
HDL-C (mmol/L) 1.68 ± 0.41 1.92 ± 0.49 -8.968 0.000
LDL-C (mmol/L) 2.57 ± 0.77 2.61 ± 0.76 -0.823 0.411
Apolipoprotein (Apo) AI (g/L) 1.32 ± 0.31 1.41 ± 0.24 -5.896 0.000
ApoB (g/L) 0.83 ± 0.23 0.91 ± 0.22 -5.771 0.000
ApoAI/ApoB 1.71 ± 0.72 1.64 ± 0.49 1.998 0.046
HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol. The value of TG was presented as median (interquartile range). The
difference between the two ethnic groups was determined by the Wilcoxon-Mann-Whitney test.
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and CC genotype is homozygote for the presence of the
site (bands at 167- and 102- bp; Figure 2). The genotype
distribution was consistent with the Hardy-Weinberg
equilibrium.
Genotypic and allelic frequencies
The genotypic and allelic frequencies of PPARD +294T > C
polymorphism are shown in Table 2. The frequency of T
and C alleles was 77.50% and 22.50% in Bai Ku Yao, and
72.43% and 27.57% in Han (P < 0.01); respectively. The fre-
quency of TT, TC and CC genotypes was 60.59%, 33.83%
and 5.53% in Bai Ku Yao, and 52.18%, 40.50% and 7.32% in
Han (P < 0.05); respectively. There was no significant differ-
ence in the genotypic and allelic frequencies between males
and females in both ethnic groups.
Results of sequencing
The results were shown as TT, TC and CC genotypes
by PCR-RFLP, the TT, TC and CC genotypes were also
confirmed by sequencing (Figure 3); respectively.
Genotypes and serum lipid levels
As shown in Table 3, the levels of LDL-C, ApoB and the
ratio of ApoAI to ApoB in Bai Ku Yao were significant
difference among the three genotypes in females but not
in males (P < 0.05 for all). The subjects with CC geno-
type had higher serum LDL-C and ApoB levels and
lower the ratio of ApoAI to ApoB than the subjects
with TT and TC genotypes in females.
The levels of TC and ApoB in the total Han popula-
tion were significant difference among the three geno-
types (P < 0.05 for all). The C allele carriers (TC and
CC genotypes) had higher serum TC and ApoB levels as
compared with the C allele noncarriers (TT genotype).
When serum lipid levels were analyzed according to sex,
the difference in serum TC levels in Han Chinese was
significant in males (P < 0.01) but not in females,
whereas the difference in serum ApoB levels was signifi-
cant in females (P < 0.05) but not in males.
There was no significant difference in the remaining
serum lipid parameters among the three genotypes in
Bai Ku Yao, Han, males, or females (P > 0.05 for all);
respectively.
Relative factors for serum lipid parameters
Multiple linear regression analysis showed that serum
TC, TG and ApoB levels were correlated with genotypes
in the combined population of Bai Ku Yao and Han
(P < 0.05 for all). Serum TC and ApoB levels were cor-
related with genotypes in Han (P < 0.05 for each) but
not in Bai Ku Yao (Table 4). Serum lipid parameters
were also correlated with sex, age, BMI, alcohol con-
sumption, cigarette smoking, and blood pressure in both
ethnic groups (Table 4).
Discussion
T h ep r e s e n ts t u d ys h o w e dt h a tt h el e v e l so fs e r u mT C ,
HDL-C, ApoAI and ApoB were lower in Bai Ku Yao
than in Han Chinese. There was no significant
Figure 1 Electrophoresis of PCR products of the samples. Lane
M, 100 bp marker ladder; lanes 1-6, samples. The 269 bp bands are
the target genes.
Figure 2 Genotyping of the PPARD +294T > C polymorphism.
Lane M, 100 bp marker ladder; lanes 1 and 2, TT genotype (269 bp);
lanes 3-5, TC genotype (269-, 167- and 102-bp); and lanes 6 and 7,
CC genotype (167- and 102-bp).
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Chinese [n (%)]
Group n Genotype Allele
TT TC CC T C
Bai Ku Yao 609 369 (60.59) 206 (33.83) 34 (5.53) 944 (77.50) 274 (22.50)
Han Chinese 573 299 (52.18) 232 (40.50) 42 (7.32) 830 (72.43) 316 (27.57)
c
2 - 8.632 8.130
P - 0.013 0.004
Bai Ku Yao
Male 288 183 (63.54) 93 (32.30) 12 (4.16) 459 (79.69) 117 (20.31)
Female 321 186 (57.95) 113 (35.20) 22 (6.85) 486 (75.47) 158 (24.53)
c
2 - 3.128 3.104
P - 0.209 0.078
Han Chinese
Male 260 146 (56.15) 97 (37.31) 17 (6.54) 392 (74.81) 132 (25.19)
Female 313 153 (48.88) 135 (43.13) 25 (7.99) 441 (70.45) 185 (29.55)
c
2 - 3.036 2.718
P - 0.219 0.099
Figure 3 A part of the nucleotide sequence of PPARD +294T > C polymorphism. (A) TT genotype; (B) TC genotype; (C) CC genotype.
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TT 369 4.35 ± 0.97 1.00(0.66) 1.67 ± 0.42 2.59 ± 0.81 1.31 ± 0.32 0.84 ± 0.22 1.69 ± 0.73
TC 206 4.29 ± 0.79 0.98(0.63) 1.69 ± 0.39 2.50 ± 0.68 1.32 ± 0.28 0.82 ± 0.24 1.74 ± 0.69
CC 34 4.63 ± 0.96 1.92(0.79) 1.72 ± 0.51 2.79 ± 0.83 1.36 ± 0.38 0.89 ± 0.25 1.68 ± 0.85
F - 1.951 0.102 0.339 2.454 0.286 1.658 0.376
P - 0.143 0.950 0.713 0.087 0.751 0.191 0.687
TT 369 4.35 ± 0.97 1.00(0.66) 1.67 ± 0.42 2.59 ± 0.81 1.31 ± 0.32 0.84 ± 0.22 1.69 ± 0.73
TC/CC 240 4.34 ± 0.82 0.97(0.73) 1.69 ± 0.41 2.53 ± 0.71 1.32 ± 0.30 0.83 ± 0.24 1.74 ± 0.72
F - 0.021 0.319 0.566 0.604 0.082 0.172 0.495
P - 0.884 0.749 0.452 0.437 0.775 0.679 0.482
Male
TT 183 4.35 ± 1.14 1.03(0.74) 1.69 ± 0.48 2.54 ± 0.96 1.35 ± 0.37 0.81 ± 0.23 1.83 ± 0.91
TC 93 4.38 ± 0.89 1.21(1.01) 1.73 ± 0.46 2.48 ± 0.79 1.38 ± 0.33 0.82 ± 0.23 1.84 ± 0.84
CC 12 4.73 ± 1.07 1.53(1.15) 1.84 ± 0.50 2.65 ± 1.01 1.52 ± 0.41 0.82 ± 0.24 2.16 ± 1.20
F - 0.758 1.263 0.753 0.220 1.286 0.073 0.740
P - 0.470 0.532 0.472 0.802 0.278 0.930 0.478
TT 183 4.35 ± 1.14 1.03(0.74) 1.69 ± 0.48 2.54 ± 0.96 1.35 ± 0.37 0.81 ± 0.23 1.83 ± 0.91
TC/CC 105 4.41 ± 0.91 1.23(1.08) 1.74 ± 0.46 2.50 ± 0.82 1.39 ± 0.34 0.82 ± 0.24 1.87 ± 0.89
F - 0.311 0.850 0.864 0.091 0.821 0.146 0.166
P - 0.578 0.395 0.353 0.763 0.366 0.703 0.684
Female
TT 186 4.36 ± 0.79 0.94(0.51) 1.66 ± 0.35 2.64 ± 0.63 1.28 ± 0.26 0.86 ± 0.20 1.55 ± 0.46
TC 113 4.23 ± 0.69 0.92(0.56) 1.67 ± 0.32 2.50 ± 0.57 1.27 ± 0.22 0.82 ± 0.24 1.66 ± 0.53
CC 22 4.57 ± 0.92 0.81(0.45) 1.65 ± 0.52 2.87 ± 0.74 1.27 ± 0.34 0.93 ± 0.21 1.41 ± 0.44
F - 2.265 0.697 0.031 3.759 0.064 3.264 3.280
P - 0.106 0.706 0.969 0.024 0.938 0.040 0.039
TT 186 4.36 ± 0.79 0.94(0.51) 1.66 ± 0.35 2.64 ± 0.63 1.28 ± 0.26 0.86 ± 0.20 1.55 ± 0.46
TC/CC 135 4.28 ± 0.74 0.91(0.54) 1.67 ± 0.36 2.57 ± 0.61 1.27 ± 0.24 0.84 ± 0.24 1.62 ± 0.52
F - 0.795 0.799 0.030 1.086 0.129 1.289 1.565
P - 0.373 0.425 0.862 0.298 0.720 0.257 0.212
Han Chinese
TT 299 4.65 ± 0.91 0.99(0.39) 1.92 ± 0.48 2.56 ± 0.67 1.40 ± 0.24 0.88 ± 0.20 1.66 ± 0.43
TC 232 4.87 ± 1.14 1.02(0.80) 1.93 ± 0.51 2.64 ± 0.81 1.42 ± 0.25 0.94 ± 0.23 1.61 ± 0.46
CC 42 4.90 ± 1.19 1.18(0.68) 1.91 ± 0.50 2.78 ± 1.01 1.42 ± 0.22 0.95 ± 0.25 1.67 ± 0.94
F - 3.194 2.428 0.041 1.964 0.449 4.601 0.742
P - 0.042 0.297 0.959 0.141 0.639 0.010 0.477
TT 299 4.65 ± 0.91 0.99(0.39) 1.92 ± 0.48 2.56 ± 0.67 1.40 ± 0.24 0.88 ± 0.20 1.66 ± 0.43
TC/CC 274 4.87 ± 1.14 1.04(0.77) 1.93 ± 0.51 2.66 ± 0.84 1.42 ± 0.25 0.94 ± 0.24 1.62 ± 0.56
F - 6.354 1.137 0.048 2.699 0.899 9.048 0.985
P - 0.012 0.255 0.827 0.101 0.344 0.003 0.321
Male
TT 146 4.59 ± 0.96 1.01(0.63) 1.87 ± 0.53 2.51 ± 0.64 1.39 ± 0.28 0.88 ± 0.19 1.63 ± 0.39
TC 97 5.01 ± 1.34 1.14(1.08) 1.85 ± 0.58 2.66 ± 0.91 1.38 ± 0.27 0.93 ± 0.24 1.58 ± 0.47
CC 17 4.78 ± 0.76 1.15(1.07) 1.93 ± 0.60 2.56 ± 0.43 1.40 ± 0.07 0.89 ± 0.24 1.84 ± 1.33
F - 4.160 2.542 0.164 1.087 0.027 1.821 1.901
P - 0.017 0.281 0.849 0.339 0.973 0.164 0.152
TT 146 4.59 ± 0.96 1.01(0.63) 1.87 ± 0.53 2.51 ± 0.64 1.39 ± 0.28 0.88 ± 0.19 1.63 ± 0.39
TC/CC 114 4.98 ± 1.27 1.14(1.02) 1.86 ± 0.55 2.64 ± 0.85 1.39 ± 0.26 0.93 ± 0.24 1.62 ± 0.67
F - 7.690 1.591 0.016 1.940 0.004 3.205 0.070
P - 0.006 0.112 0.900 0.165 0.951 0.075 0.792
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Page 7 of 13difference in the serum levels of TG, LDL-C and the
ratio of ApoAI to ApoB between the two ethnic groups.
As aforementioned, dyslipidemia is a multifactorial ori-
gin, including hereditary and acquired risk factors and
their interactions [11,12]. Bai Ku Yao is a special and
isolated subgroup of the Yao minority in China. They
reside in two villages, Lihu and Baxu, Nandan County.
Both Lihu and Baxu villages are typical infertile moun-
tain region, usually it was called 30 percent soil with 70
percent rock. Thus, their income mostly comes from
planting corn and paddy. Strict intra-ethnic marriages
have been performed in this ethnic subgroup from time
immemorial. Therefore, we believe that the variation of
some lipid metabolism-related genes in this population
may be different from those in Han Chinese.
The genotypic and allelic distribution of PPARD
+294T > C polymorphism was different in diverse popu-
lations. Several previous studies have showed that the
frequency of the rare allele (PPARD +294C) was signifi-
cantly higher in Russian endurance-oriented athletes
than in controls (18.3% vs. 12.1%, P < 0.0001) [42], in
Tunisian CAD patients than in healthy volunteers
(32.0% vs. 18.9%, P = 0.001) [34], and in Chinese CAD
patients than in normal controls (30.8% vs. 19.5%, P <
0.05) [35]. Some studies, however, showed that there
was no difference in its frequency between the patients
with diabetes mellitus type 2 and the non-diabetic con-
trols (18.7% versus 19.2%, P > 0.999) [37], or among the
patients with metabolic syndrome, essential hyperten-
sion and diabetes mellitus type 2 [30]. In the present
study, we showed that the frequency of PPARD +294C
allele was lower in Bai Ku Yao (22.50%) than in Han
Chinese (27.57%). The frequency of TC and CC geno-
types was also lower in Bai Ku Yao than in Han. How-
ever, the frequency of PPARD +294C allele was higher
in both ethnic groups than in 543 healthy 50-year-old-
men (15.6%) from the northern part of the greater
Stockholm area [28], in normal controls (19.5%) from
Chinese Anhui Province [35], in healthy Tunisian popu-
lation (18.9%) [34], and in non-diabetic Germany con-
trols (19.2%) [37]; but it was lower than in Tunisian
CAD patients (32.0%) [34] and Chinese CAD patients
(30.8%) [35]. These results indicate that the prevalence
of the C allele variants of PPARD +294T > C poly-
morphism may have an ethnic specificity.
The association of PPARD +294T > C polymorphism
and plasma or serum lipid levels in humans has been
evaluated in several previous studies. However, the find-
ings are inconsistent. Skogsberg et al. [28] demonstrated
that this SNP was implicated in cholesterol metabolism
in Swedish men. Homozygotes for the rare C allele had
a higher plasma LDL-C concentration than homozygotes
for the common T allele, which was verified in an inde-
pendent cohort consisting of 282 healthy men, while
there were no associations with the HDL-C levels. Inter-
estingly, the same group of investigators showed in
another study in Scottish men that the SNP did not
influence LDL-C concentrations but was associated with
lower HDL-C levels. Individuals carrying the rare C
allele had a significantly lower HDL-C concentration
than subjects homozygous for the common T allele [29].
Moreover, Aberle et al. [31] showed a highly significant
association between the rare C allele and lower plasma
HDL-C concentrations in dyslipidemic female subjects.
The effect remained significant after correcting for mul-
tiparametric testing according to Bonferoni and was
seen only in subjects with a BMI below the median. In
addition, several recent reports have also uniformly
showed that the PPARD +294T > C polymorphism was
associated with some serum lipid phenotypes. For exam-
ple, metabolic syndrome patients with CC genotype had
significantly higher TC and LDL-C levels than those
with TT and TC genotypes [30]. Among subjects with
and without type 2 diabetes, the PPARD +294T > C
polymorphism was associated with HDL-C and was
dependent on sex [32]. The risk variant of PPARD
Table 3: Genotypic frequencies of the PPARD +294T > C polymorphism and serum lipid levels between the Bai Ku Yao
and Han populations (Continued)
Female
TT 153 4.71 ± 0.85 0.97(0.56) 1.96 ± 0.44 2.60 ± 0.70 1.42 ± 0.20 0.89 ± 0.21 1.68 ± 0.46
TC 135 4.76 ± 0.95 0.95(0.68) 1.98 ± 0.45 2.63 ± 0.73 1.45 ± 0.23 0.94 ± 0.23 1.63 ± 0.45
CC 25 4.98 ± 1.43 1.19(0.57) 1.90 ± 0.44 2.93 ± 1.25 1.44 ± 0.25 0.99 ± 0.26 1.54 ± 0.52
F - 0.887 2.362 0.406 2.009 0.822 3.265 1.120
P - 0.413 0.307 0.667 0.136 0.441 0.039 0.328
TT 153 4.71 ± 0.85 0.97(0.56) 1.96 ± 0.44 2.60 ± 0.70 1.42 ± 0.20 0.89 ± 0.21 1.68 ± 0.46
TC/CC 160 4.73 ± 1.04 0.99(0.65) 1.97 ± 0.45 2.67 ± 0.83 1.45 ± 0.23 0.94 ± 0.23 1.61 ± 0.46
F - 0.584 0.196 0.046 0.757 1.555 5.419 1.493
P - 0.445 0.844 0.830 0.385 0.213 0.021 0.223
TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoAI, apolipoprotein AI; ApoB,
apolipoprotein B; ApoAI/ApoB, the ratio of apolipoprotein AI to apolipoprotein B. The value of TG was presented as median (interquartile range). The difference
among the genotypes was determined by the Kruskal-Wallis test or the Wilcoxon-Mann-Whitney test.
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Page 8 of 13Table 4 Correlative factors for serum lipid parameters between Bai Ku Yao and Han Chinese
Lipid parameter Risk factor Unstandardized coefficient Std. error Standardized coefficient tP
Yao plus Han
TC Body mass index 0.065 0.010 0.177 6.332 0.000
Ethnic group 0.373 0.055 0.187 6.810 0.000
Age 0.009 0.002 0.140 4.926 0.000
Diastolic blood pressure 0.009 0.003 0.094 3.248 0.001
Genotype 0.087 0.045 0.054 1.963 0.050
TG Body mass index 0.097 0.014 0.195 6.963 0.000
Alcohol consumption 0.174 0.042 0.131 4.122 0.000
Sex -0.257 0.087 -0. 094 -2.967 0.003
Genotype 0.123 0.062 0.056 1.980 0.048
HDL-C Ethnic group 0.250 0.025 0.266 9.840 0.000
Age 0.006 0.001 0.191 6.979 0.000
Alcohol consumption 0.086 0.014 0.187 6.035 0.000
Sex 0.111 0.029 0.117 3.846 0.000
Body mass index -0.017 0.005 -0.102 -3.763 0.000
LDL-C Body mass index 0.054 0.008 0.194 6.870 0.000
Age 0.007 0.001 0.135 4.724 0.000
Alcohol consumption -0.087 0.021 -0.116 -4.055 0.000
ApoAI Alcohol consumption 0.067 0.009 0.240 7.605 0.000
Ethnic group 0.101 0.016 0.177 6.432 0.000
Age 0.003 0.001 0.165 5.903 0.000
Sex 0.040 0.018 0.070 2.235 0.026
ApoB Body mass index 0.017 0.002 0.200 7.125 0.000
Age 0.003 0.000 0.191 6.656 0.000
Ethnic group 0.066 0.013 0.145 5.284 0.000
Alcohol consumption -0.019 0.006 -0.087 -3.078 0.002
Diastolic blood pressure 0.001 0.001 0.068 2.310 0.021
Genotype 0.023 0.010 0.065 2.234 0.026
ApoAI/ApoB Alcohol consumption 0.133 0.017 0.218 7.608 0.000
Body mass index -0.034 0.006 -0.148 -5.250 0.000
Age -0.002 0.001 -0.062 -2.169 0.030
Bai Ku Yao
TC Body mass index 0.072 0.015 0.189 4.776 0.000
Age 0.008 0.002 0.142 3.598 0.000
TG Alcohol consumption 0.094 0.040 0.110 2.329 0.020
Body mass index 0.054 0.015 0.139 3.503 0.000
Sex -0.238 0.087 -0.128 -2.735 0.006
HDL-C Alcohol consumption 0.069 0.015 0.180 4.547 0.000
Age 0.005 0.001 0.171 4.335 0.000
LDL-C Body mass index 0.063 0.013 0.196 4.954 0.000
Age 0.006 0.002 0.129 3.245 0.001
Cigarette smoking -0.062 0.025 -0.097 -2.446 0.015
ApoAI Alcohol consumption 0.082 0.011 0.283 7.324 0.000
Age 0.003 0.001 0.136 3.523 0.000
ApoB Body mass index 0.020 0.004 0.208 5.286 0.000
Age 0.002 0.001 0.167 4.209 0.000
Alcohol consumption -0.023 0.008 -0.109 -2.753 0.006
ApoAI/ApoB Alcohol consumption 0.197 0.026 0.295 7.605 0.000
Han Chinese
TC Diastolic blood pressure 0.013 0.004 0.135 3.235 0.001
Body mass index 0.060 0.014 0.176 4.350 0.000
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Page 9 of 13+294T > C marker was associated with higher LDL-C
and increased serum TC [33]. However, Gouni-Berthold
et al. [37] found that the presence of the C allele had
no effect on TG, HDL-C, and LDL-C levels, both in dia-
betic and non-diabetic German controls, or both in men
and in women. The same result was found by Jguirim-
Souissi et al. [34] both in CAD patients and healthy
controls. In the present study, we showed that the levels
of LDL-C, ApoB and the ratio of ApoAI to ApoB in Bai
Ku Yao were significant difference among the three gen-
otypes in females but not in males. The subjects with
CC genotype in females had higher serum LDL-C and
ApoB levels and lower the ratio of ApoAI to ApoB than
the subjects with TT and TC genotypes. In contrast, the
levels of TC and ApoB in the total Han population were
significant difference among the three genotypes. The C
allele carriers had higher serum TC and ApoB levels as
compared with the C allele noncarriers. When serum
lipid levels were analyzed according to sex, the differ-
ence in serum TC levels in Han Chinese was significant
in males but not in females, whereas the difference in
serum ApoB levels was significant in females but not in
males. Serum TC and ApoB levels were correlated with
genotypes in Han but not in Bai Ku Yao. These results
suggest that the association of PPARD +294T > C poly-
morphism and serum lipid levels is different between
the Bai Ku Yao and Han populations. The discrepancy
between the two ethnic groups might partly result from
different PPARD +294T > C polymorphism or PPARD
gene-enviromental interactions.
In the present study, we also found that serum lipid
parameters were associated with age, sex, alcohol con-
sumption, cigarette smoking, BMI, and blood pressure.
These results suggest that the environmental factors
also play important roles in dyslipidemia in our popula-
tions [6,7]. The dietary patterns and lifestyle between
the two ethnic groups were different. The staple food
was corn and the subsidiary foods were rice, soy, buck-
wheat, sweet potato, and pumpkin products in Bai Ku
Yao. Approximately 90% of the beverages were corn
wine and rum. The alcohol content is about 15% (v/v).
The people of Bai Ku Yao are also accustomed to drink
hempseed soup and eat hempseed products. In contrast,
rice was the staple food and corn, broomcorn, potato,
and taro products were the subsidiary foods in Han.
About 90% of the beverage was rice wine. The content
of alcohol is about 30% (v/v). The staple and subsidiary
foods are more favorable for serum lipid profiles in Bai
K uY a ot h a ni nH a n .C o r nc o n t a i n sa b u n d a n td i e t a r y
fiber and plant protein [43]. Consumption of dietary
fiber can decrease serum lipid levels [44,45]. A dietary
supplement of water-soluble fibers (guar gum, pectin)
and mostly non-water-soluble fibers (soy fiber, pea fiber,
corn bran) in subjects with mild to moderate hypercho-
lesterolemia (LDL-C, 3.37-4.92 mmol/L) had significant
blood cholesterol-lowering effects. The mean decreases
during the 15-week period for LDL-C, TC, and LDL-C/
HDL-C ratio were greater (P < 0.001) in the fiber group.
The mean changes from pre-treatment values in LDL-C,
TC, and LDL-C/HDL-C ratio for subjects in the fiber
Table 4: Correlative factors for serum lipid parameters between Bai Ku Yao and Han Chinese (Continued)
Age 0.010 0.003 0.163 3.964 0.000
Genotype 0.136 0.065 0.083 2.081 0.038
TG Body mass index 0.127 0.022 0.226 5.648 0.000
Alcohol consumption 0.353 0.071 0.198 4.954 0.000
HDL-C Age 0.008 0.001 0.242 5.975 0.000
Body mass index -0.023 0.006 -0.140 -3.557 0.000
Sex 0.158 0.042 0.160 3.760 0.000
Alcohol consumption 0.072 0.022 0.140 3.211 0.001
LDL-C Body mass index 0.046 0.010 0.185 4.584 0.000
Alcohol consumption -0.119 0.033 -0.150 -3.610 0.000
Age 0.007 0.002 0.148 3.575 0.000
ApoAI Age 0.004 0.001 0.232 5.694 0.000
Sex 0.082 0.021 0.168 3.917 0.000
Alcohol consumption 0.039 0.011 0.155 3.527 0.000
ApoB Age 0.003 0.001 0.239 6.076 0.000
Body mass index 0.016 0.003 0.218 5.540 0.000
Genotype 0.035 0.014 0.098 2.498 0.013
ApoAI/ApoB Body mass index -0.032 0.007 -0.197 -4.794 0.000
TC, total cholesterol; TG, triglyceride; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; ApoAI, apolipoprotein AI; ApoB,
apolipoprotein B.
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Page 10 of 13group were -0.51 mmol/L (-12.1%), -0.53 mmol/L
(-8.5%), and -0.30 (-9.4%); respectively. But the fiber
supplement had no significant effects on HDL-C and
TG [45]. Plant protein might promote the transportation
and excretion of free cholesterol. Dietary soy protein has
well-documented beneficial effects on serum lipid con-
centrations [46,47]. Soy protein with isoflavones intact
was associated with significant decreases in serum TC
(by 0.22 mmol/L, or 3.77%), LDL-C (by 0.21 mmol/L, or
5.25%), and TG (by 0.10 mmol/L, or 7.27%) and signifi-
cant increases in serum HDL-C (by 0.04 mmol/L, or
3.03%). The reductions in total and LDL-C were larger
in men than in women. Initial TC concentrations had a
powerful effect on changes in total and HDL-C, espe-
cially in subjects with hypercholesterolemia. Studies
with intakes > 80 mg showed better effects on the lipid
profile. The strongest lowering effects of soy protein
containing isoflavones on TC, LDL-C, and TG occurred
within the short initial period of intervention, whereas
improvements in HDL-C were only observed in studies
of > 12 wk duration [47]. Buckwheat protein product
has a potent hypocholesterolemic activity [48,49].
Plasma TC concentrations in rats fed a cholesterol-free
diet with tartary buckwheat sprout powder were signifi-
cantly lower than in the control rats fed a diet with
alpha-cornstarch. The cholesterol-lowering function of
tartary buckwheat sprout powder may be achieved by
enhancing fecal bile acid excretion through increased
fecal matter excretion or the upregulation of hepatic
cholesterol 7alpha-hydroxylase mRNA expression [49].
I n g e s t i o no f4g / d a yc a i a p o( t h ee x t r a c to ft h ew h i t e -
skinned sweet potato Ipomoea batatas) for 6 weeks has
been found to reduce plasma TC and LDL-C levels in
type 2 diabetic patients previously treated by diet alone
[50]. Chang et al. [51] have evaluated the effect of pur-
ple sweet potato leaves (PSPLs) consumption on antioxi-
dative status and its modulation of that status in
basketball players during training period. The results
showed that LDL lag time was significantly longer in the
PSPLs group, sugesting that consumption of PSPLs diet
for 2 weeks may reduce lipid and DNA oxidation that
can modulate the antioxidative status of basketball
players during training period. Adaramoye et al.[ 5 2 ]
reported that supplemented diets containing 3% and 6%
telfairia occidentalis (fluted pumpkin) in rats decreased
plasma and postmitochondrial supernatant fraction
(PMF) cholesterol levels by 20% and 30% and by 30%
and 45%, respectively; decreased the cholesterol-induced
increase in plasma and PMF LDL-C levels by 24% and
48% and by 28% and 52%, respectively; and decreased
plasma and PMF lipid peroxidation by 24% and 20%
and by 42% and 21%, respectively. Hempseed contains a
high proportion of the polyunsaturated fatty acids
(PUFAs) such as linoleic acid, linolenic acid, oleic acid,
palmitic acid, and stearic acid, which may have benefi-
cial effects on serum lipid profiles. Hempseed-
supplemented diet in animals displayed elevated plasma
levels of PUFAs and a prominent enhancement in
gamma-linolenic acid levels. When hempseed is added
to a cholesterol-enriched diet, cholesterol-induced plate-
let aggregation returns to control levels [53,54]. This
normalization may be partly due to increased levels of
plasma gamma-linolenic acid [53]. In addition, several
experimental and clinical studies have demonstrated
that dietary hempseed or hempseed oil can decrease
serum TC, TG and LDL-C levels [55-57], inhibit lipid
peroxidation [58], and reduce atherogenic index [59].
Conclusion
The present study shows that the frequency of PPARD
+294C allele was lower in Bai Ku Yao than in Han
Chinese. The subjects with CC genotype in Bai Ku Yao
had higher serum LDL-C and ApoB levels and lower the
ratio of ApoAI to ApoB than the subjects with TT and
TC genotypes in females but not in males. The C allele
carriers in Han Chinese had higher serum TC and ApoB
levels than the C allele noncarriers. When serum lipid
levels were analyzed according to sex, the difference in
serum TC levels in Han Chinese was significant in males
but not in females, whereas the difference in serum ApoB
levels was significant in females but not in males. Serum
TC and ApoB levels were correlated with genotypes in
H a nb u tn o ti nB a iK uY a o .T h e s er e s u l t ss u g g e s tt h a t
the association of PPARD +294T > C polymorphism and
serum lipid levels is different between the Bai Ku Yao
and Han populations. The difference in the association of
PPARD +294T > C polymorphism and serum lipid levels
between the two ethnic groups might partly result from
different PPARD +294T > C polymorphism or PPARD
gene-enviromental interactions.
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